1. Assigning functionality to cysteines by base editing of cancer dependency genes
- Author
-
Li, Haoxin, Ma, Tiantai, Remsberg, Jarrett R, Won, Sang Joon, DeMeester, Kristen E, Njomen, Evert, Ogasawara, Daisuke, Zhao, Kevin T, Huang, Tony P, Lu, Bingwen, Simon, Gabriel M, Melillo, Bruno, Schreiber, Stuart L, Lykke-Andersen, Jens, Liu, David R, and Cravatt, Benjamin F
- Subjects
Biochemistry and Cell Biology ,Bioinformatics and Computational Biology ,Biological Sciences ,Genetics ,Biotechnology ,Cancer ,Underpinning research ,1.1 Normal biological development and functioning ,Generic health relevance ,Humans ,Cysteine ,Proteomics ,Gene Editing ,Proteome ,Neoplasms ,Nuclear Proteins ,Medicinal and Biomolecular Chemistry ,Biochemistry & Molecular Biology ,Biochemistry and cell biology ,Medicinal and biomolecular chemistry - Abstract
Covalent chemistry represents an attractive strategy for expanding the ligandability of the proteome, and chemical proteomics has revealed numerous electrophile-reactive cysteines on diverse human proteins. Determining which of these covalent binding events affect protein function, however, remains challenging. Here we describe a base-editing strategy to infer the functionality of cysteines by quantifying the impact of their missense mutation on cancer cell proliferation. The resulting atlas, which covers more than 13,800 cysteines on more than 1,750 cancer dependency proteins, confirms the essentiality of cysteines targeted by covalent drugs and, when integrated with chemical proteomic data, identifies essential, ligandable cysteines in more than 160 cancer dependency proteins. We further show that a stereoselective and site-specific ligand targeting an essential cysteine in TOE1 inhibits the nuclease activity of this protein through an apparent allosteric mechanism. Our findings thus describe a versatile method and valuable resource to prioritize the pursuit of small-molecule probes with high function-perturbing potential.
- Published
- 2023